This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Tyson Foods (TSN) Q2 Earnings Beat Estimates, Sales Improve
by Zacks Equity Research
Tyson Foods (TSN) second-quarter fiscal 2019 results gain from growth in beef and chicken categories.
TreeHouse (THS) Q1 Earnings Beat Estimates, Sales Decline
by Zacks Equity Research
TreeHouse (THS) continues to witness adverse impacts from divestiture and SKU rationalization in Q1.
Kellogg (K) Q1 Earnings Beat Estimates, Buyout Boosts Sales
by Zacks Equity Research
Kellogg (K) first-quarter 2019 earnings decline year over year, while sales improve on the back of acquisitions.
Avon (AVP) Q1 Earnings Beat Estimates, Sales Miss Hurts Stock
by Zacks Equity Research
Avon's (AVP) Q1 earnings gain from strong operating margin growth and effective execution of the Open Up strategy. However, soft Representatives across segments and adverse currency hurt the top line.
Pilgrim's Pride (PPC) Misses on Q1 Earnings and Revenues
by Zacks Equity Research
Pilgrim's Pride's (PPC) Q1 results hurt by tough chicken market in Mexico and high input costs in Europe.
Estee Lauder (EL) Q3 Earnings & Sales Beat, Outlook Raised
by Zacks Equity Research
Estee Lauder's (EL) top and bottom lines improve year over year and surpass estimates in Q3. The company continues to gain from strength in most categories.
Mondelez's (MDLZ) Q1 Earnings Beat Estimates, Sales Decline
by Zacks Equity Research
Gains from pricing support Mondelez's (MDLZ) Q1 results. However, adverse currency impact is a drag on top line.
Can Cost Inflation Weigh on Tyson Foods' (TSN) Q2 Earnings?
by Zacks Equity Research
Tyson Foods (TSN) Q1 results to gain from strength in chicken and beef categories. However, rising input costs and sluggish pork unit are concerns.
Medifast's (MED) Q1 Earnings to Gain From OPTAVIA Brands
by Zacks Equity Research
Sturdy growth in the OPTAVIA banner is likely to boost Medifast's (MED) Q1 results. However, rising freight and SG&A expenses are concerns.
Will Chicken Woes Linger in Pilgrim's Pride (PPC) Q1 Earnings?
by Zacks Equity Research
Pilgrim's Pride (PPC) Q1 results is likely to be hurt by volatility in commodity chicken market. Nevertheless, strength in the Prepared Food unit bodes well.
Estee Lauder (EL) Soars to 52-Week High, Time to Cash Out?
by Zacks Equity Research
Estee Lauder (EL) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Is Disappointment in Store for B&G Foods (BGS) in Q1 Earnings?
by Zacks Equity Research
B&G Foods' (BGS) margins are under pressure due to increased freight costs. Also, Pirate Brands' divestiture is likely to weigh on sales in Q1, though buyouts should offer some cushion to the stock.
Factors to Watch Ahead of Hanesbrands' (HBI) Q1 Earnings
by Zacks Equity Research
Hanesbrands (HBI) is likely to witness organic sales growth in Q1. However, raw-material inflation is a threat.
Will High Costs & Weak Units Hurt Kellogg's (K) Q1 Earnings?
by Zacks Equity Research
Rising input costs, currency headwinds and weak units are likely to dent Kellogg's (K) Q1 performance.
Organic Sales to Drive Church & Dwight (CHD) in Q1 Earnings
by Zacks Equity Research
Church & Dwight's (CHD) first-quarter 2019 results are set to gain on organic sales growth. Also, acquisitions are likely to serve as tailwinds, while high costs are a concern.
Factors Likely to Decide Avon's (AVP) Fate in Q1 Earnings
by Zacks Equity Research
Soft Representatives growth and currency headwind are likely to mar Avon's (AVP) Q1 results. However, the Open Up Avon strategy may bring some respite.
Will Mondelez (MDLZ) Post Q1 Earnings Beat Amid Hurdles?
by Zacks Equity Research
Mondelez's (MDLZ) Q1 earnings to gain from savings efforts. However, high input costs and adverse currency rates are concerns.
Estee Lauder (EL) to Post Q3 Earnings: Is a Beat in Store?
by Zacks Equity Research
Estee Lauder's (EL) third-quarter fiscal 2019 results are set to gain on strong travel retail network, buyouts and opportunities in the global prestige beauty industry, among other factors.
Here's What You Must Note Ahead of Nu Skin (NUS) Q1 Earnings
by Zacks Equity Research
Nu Skin's (NUS) is likely to benefit from effective marketing programs, gains from social media and a solid sales leaders' network. These factors are set to drive customer count in Q1.
Helen of Troy (HELE) to Post Q4 Earnings: Things Not So Rosy
by Zacks Equity Research
Helen of Troy (HELE) is expected to be hurt by soft Beauty unit sales, tariff impacts and adverse mix in Q4 earnings season. However, strength in Leadership Brands will aid the stock.
Why Inter Parfums (IPAR) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Inter Parfums (IPAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
All You Need to Know About Inter Parfums (IPAR) Rating Upgrade to Buy
by Zacks Equity Research
Inter Parfums (IPAR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Can Helen of Troy's Restructuring Efforts Pare Hurdles?
by Zacks Equity Research
Helen of Troy is on track with Project Refuel and strength in online platform. However, soft beauty unit is a worry.
Avon (AVP) Stock Rallies on Likely Takeover Bid From Natura
by Zacks Equity Research
Avon (AVP) gets a boost as the beauty company based in Brazil, Natura confirms about takeover talks between these two, which is still in early stages.
Coty's (COTY) Luxury Unit Strong, Consumer Beauty Woes Remain
by Zacks Equity Research
Coty (COTY) is largely benefitting from strength of its Luxury segment that accounted for about 40% of the top line in Q2. However, supply-chain hurdles continue to mar Consumer Beauty unit.